Back to Journals » Drug Design, Development and Therapy » Volume 13

Review

Quizartinib (AC220): a promising option for acute myeloid leukemia

       
Total article views   HTML views PDF downloads Totals
12,407 Dovepress* 9,881+ 1,746 11,627
PubMed Central* 2,526 742 3,268
Totals 12,407 2,488 14,895
*Since 8 April 2019

View citations on PubMed Central and Google Scholar